Prognosis

Recurrence

The 3-year cumulative risk of a subsequent squamous cell carcinoma (SCC) after an index SCC is 18%. This is at least a 10-fold increase in incidence compared with the incidence of first tumours in a comparable general population.[127] Between 70% and 80% of recurrences occur within 2 years of initial therapy.[75]

Prognosis depends on the depth of tumour invasion, histological pattern, and immunological status of the patient.[128][129][130]​​

Metastasis

Generally the metastatic potential of SCC is low; approximately 2% to 4% of tumours metastasise.[75][130][131] Increased depth of invasion of SCC and size is strongly associated with local recurrence, metastasis, and death. Metastases are more common in tumours of the ear (10%) or lip (30%), scalp, and extremities, and especially in patients who have received immunosuppressive therapy. For those with metastatic disease, the long-term prognosis is extremely poor.[131] Ten-year survival rates are <20% for patients with regional lymph node involvement and <10% for patients with distant metastases.

Use of this content is subject to our disclaimer